Novel 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors which are useful as antihypercholesterolemic agents and are represented by the following general structural formulae (I) and (II):
and pharmaceutically acceptable salts of the compounds (II) in which Z is hydrogen are disclosed.
新型 3-羟基-3-甲基戊二酰辅酶 A(HMG-CoA)还原酶抑制剂,可用作抗胆固醇血症药物,由以下结构通式(I)和(II)表示:
以及 Z 为氢的化合物(II)的药学上可接受的盐。
HOFFMAN, WILLIAM F.;ROONEY, CLARENCE S.;LEE, TA J.
作者:HOFFMAN, WILLIAM F.、ROONEY, CLARENCE S.、LEE, TA J.
DOI:——
日期:——
BOURGEOIS, M. J.;MONTAUDON, E.;CAMPAGNOLE, M.;MAILLARD, B., BULL. SOC. CHIM. BELG., 1982, 91, N 10, 871-872
作者:BOURGEOIS, M. J.、MONTAUDON, E.、CAMPAGNOLE, M.、MAILLARD, B.
DOI:——
日期:——
Bourgeois, M. J.; Montaudon, E.; Campagnole, M., Bulletin des Societes Chimiques Belges, 1982, vol. 91, # 10, p. 871 - 872
作者:Bourgeois, M. J.、Montaudon, E.、Campagnole, M.、Maillard, B.